Ignite Creation Date:
2024-05-06 @ 2:30 PM
Last Modification Date:
2024-10-26 @ 1:32 PM
Study NCT ID:
NCT04337658
Status:
NOT_YET_RECRUITING
Last Update Posted:
2020-04-08
First Post:
2020-01-11
Brief Title:
Anti-HER2 Therapy FulvestrantCapecitabine in Women With HR HER2 Non-visceral Metastases Stage IV Breast Cancer
Sponsor:
Second Affiliated Hospital School of Medicine Zhejiang University
Organization:
Second Affiliated Hospital School of Medicine Zhejiang University
Organization Data
Organization:
Second Affiliated Hospital School of Medicine Zhejiang University
Class:
OTHER
Study ID:
FAVOR
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Second Affiliated Hospital School of Medicine Zhejiang University
Lead Sponsor Class:
OTHER
Responsible Party:
xuexin he
Responsible Party Title:
Principal Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Second Affiliated Hospital School of Medicine Zhejiang University
Old Name:
None
Old Organization:
None